NAPODANO, MASSIMO
 Distribuzione geografica
Continente #
NA - Nord America 9.955
EU - Europa 1.266
AS - Asia 664
SA - Sud America 9
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 3
AF - Africa 1
Totale 11.904
Nazione #
US - Stati Uniti d'America 9.948
CN - Cina 501
FI - Finlandia 296
SE - Svezia 250
DE - Germania 198
GB - Regno Unito 153
IT - Italia 147
UA - Ucraina 130
VN - Vietnam 88
IN - India 63
NL - Olanda 37
IE - Irlanda 28
FR - Francia 9
BR - Brasile 7
CA - Canada 7
BE - Belgio 6
EU - Europa 6
TR - Turchia 4
PK - Pakistan 3
RU - Federazione Russa 3
AU - Australia 2
BG - Bulgaria 2
EC - Ecuador 2
GR - Grecia 2
JP - Giappone 2
SG - Singapore 2
BY - Bielorussia 1
CH - Svizzera 1
EG - Egitto 1
HU - Ungheria 1
LU - Lussemburgo 1
NZ - Nuova Zelanda 1
PH - Filippine 1
RO - Romania 1
Totale 11.904
Città #
Fairfield 1.601
Chandler 1.131
Woodbridge 897
Houston 789
Ann Arbor 665
Ashburn 659
Wilmington 578
Jacksonville 572
Cambridge 549
Seattle 547
Princeton 249
San Diego 188
Medford 144
Beijing 134
Roxbury 134
Nanjing 123
Helsinki 121
Des Moines 110
Dong Ket 88
Boardman 86
Padova 43
Nanchang 31
New York 30
Dublin 28
Hebei 28
London 28
Ogden 28
Amsterdam 27
Guangzhou 26
Shenyang 26
Falls Church 24
Norwalk 23
Changsha 16
Jiaxing 16
Redwood City 16
Dearborn 14
Hefei 13
Tianjin 13
Kharkiv 11
Jinan 9
Kilburn 8
Orange 8
Indiana 7
Cagliari 6
Munich 6
Schio 6
São Paulo 6
Genoa 5
Haikou 5
Hangzhou 5
Kunming 5
Rockville 5
Borås 4
Carol Stream 4
Easton 4
Fuzhou 4
Los Angeles 4
Ningbo 4
Temecula 4
Zhengzhou 4
Berlin 3
Chiswick 3
Costa Mesa 3
Detroit 3
Hounslow 3
Istanbul 3
Milan 3
New Bedfont 3
Prescot 3
Shanghai 3
Taizhou 3
Treviso 3
Venice 3
Wandsworth 3
Acton 2
Brindisi 2
Cesano Maderno 2
Esslingen am Neckar 2
Foggia 2
Fort Worth 2
Frankfurt am Main 2
Groningen 2
Marostica 2
Moscow 2
Mussolente 2
Nürnberg 2
Paris 2
Parma 2
Phoenix 2
Pune 2
Quito 2
Redmond 2
Rome 2
San Francisco 2
San Severino Marche 2
Sofia 2
Strasbourg 2
Tokyo 2
Toronto 2
Walnut 2
Totale 10.013
Nome #
Unravelling the (arte)fact of increased pacemaker rate with the Edwards SAPIEN 3 valve 135
Three-dimensional electroanatomical voltage mapping and histologic evaluation of myocardial substrate in right ventricular outflow tract tachycardia. 128
2-year results of CoreValve implantation through the subclavian access: A propensity-matched comparison with the femoral access 127
Postconditioning during coronary angioplasty in acute myocardial infarction: the POST-AMI trial. 121
Impact of preoperative mitral valve regurgitation on outcomes after transcatheter aortic valve implantation. 121
Incidence, Predictors, and Outcome of Conduction Disorders After Transcatheter Self-Expandable Aortic Valve Implantation. 116
Early and mid-term outcomes of 1904 patients undergoing transcatheter balloon-expandable valve implantation in Italy: results from the Italian Transcatheter Balloon-Expandable Valve Implantation Registry (ITER) 113
PCI Versus CABG for Multivessel Coronary Disease in Diabetics 110
Atrial septal mass: Transesophageal echocardiographic assessment 109
Transcatheter aortic valve implantation in patients with severe left ventricular dysfunction: immediate and mid-term results, a multicenter study. 105
Design and methodologies of the POSTconditioning during coronary angioplasty in acute myocardial infarction (POST-AMI) trial. 103
Coronary vasospasm complicated by ventricular fibrillation: arrhythmogenic morphological substrates detected in vivo by cardiac magnetic resonance. 103
Impact of Changes in Left Ventricular Ejection Fraction on Survival After Transapical Aortic Valve Implantation 101
Development and validation of a distal embolization risk score during primary angioplasty in ST-elevation myocardial infarction 100
Atypical (mid-ventricular) Takotsubo syndrome in a survival of out-of-hospital ventricular fibrillation: cause or consequence? 99
A gender based analysis of predictors of all cause death after transcatheter aortic valve implantation. 99
Safety and effectiveness of a selective strategy for coronary artery revascularization before transcatheter aortic valve implantation. 99
Cardiac rehabilitation after transcatheter versus surgical prosthetic valve implantation for aortic stenosis in the elderly. 95
Transcatheter aortic valve replacement for degenerative bioprosthetic surgical valves: Results from the global valve-in-valve registry 95
Comparison of balloon-expandable versus self-expandable valves for transcatheter aortic valve implantation in patients with low-gradient severe aortic stenosis and preserved left ventricular ejection fraction 94
Trans-subclavian versus transapical access for transcatheter aortic valve implantation: A multicenter study 93
PCI versus CABG for multivessel coronary disease in diabetics 93
Transcatheter aortic valve implantation: 3-year outcomes of self-expanding CoreValve prosthesis. 91
Predictors and time-related impact of distal embolization during primary angioplasty 91
The "plastic healing concept": Implantation of bioabsorbable scaffolds in spontaneous coronary artery dissection 91
Impact of diabetes mellitus on early and midterm outcomes after transcatheter aortic valve implantation (from a multicenter registry). 91
Usefulness and Validation of the Survival posT TAVI Score for Survival After Transcatheter Aortic Valve Implantation for Aortic Stenosis. 91
Clinical outcome of patients with de novo coronary bifurcation lesions treated with the Tryton Side Branch Stent. The SAFE-TRY prospective multicenter single arm study. 90
Myocardial abnormalities underlying persistent ST-segment elevation after anterior myocardial infarction 90
Coronary Flow Velocity Reserve by Contrast-Enhanced Transthoracic Echocardiography Predicts Maximal Epicardial Intimal Thickening in Cardiac Allograft Vasculopathy 89
TAVR with mechanically expandable prostheses: Is balloon aortic valvuloplasty really necessary? 89
Impact of myocardial staining on In-hospital outcome after primary percutaneous coronary intervention in the Padua Registry on ST-elevation myocardial infarction 88
Gender-related differences of diabetic patients undergoing percutaneous coronary intervention with drug-eluting stents: A real-life multicenter experience. 88
Management and long-term prognosis of spontaneous coronary artery dissection 87
Late stent fracture - A potential role of left ventricular dilatation 87
Drug-eluting stents for the treatment of coronary lesions in cardiac transplant vasculopathy: acute and mid-term clinical and angiographic outcomes 85
Comparison between sirolimus- and paclitaxel-eluting stents for the treatment of older patients affected by coronary artery disease: results from a single-center allcomers registry. 85
Left ventricular pseudoaneurysm after transapical aortic valve-in-valve implantation: Use of transthoracic 3D echocardiography for guiding therapeutic approach 85
Clinical impact of persistent left bundle-branch block after transcatheter aortic valve implantation with CoreValve revalving system 85
Influence of transmurality infarct size, and severe microvascular obstruction on left ventricular remodeling and function after primary coronary angioplasty 85
The impact of calcium volume and distribution in aortic root injury related to balloon-expandable transcatheter aortic valve replacement 84
High-risk percutaneous coronary intervention using the intracardiac microaxial pump 'Impella Recover' 84
Unravelling the (arte)fact of increased pacemaker rate with the Edwards SAPIEN 3 valve. 84
Management and outcome of spontaneous coronary artery dissection: Conservative therapy versus revascularization 83
Anatomical and procedural features associated with aortic root rupture during balloon-expandable transcatheter aortic valve replacement. 83
Causes and timing of death during long-term follow-up after transcatheter aortic valve replacement. 83
Paravalvular leak after CoreValve implantation in the Italian Registry: Predictors and impact on clinical outcome 83
Relation of aortic valve weight to severity of aortic stenosis. 83
Adjunctive Thrombectomy in Acute Myocardial Infarction: For Some but Not for All 83
Atrial septal mass: Transesophageal echocardiographic assessment 82
Chronic kidney disease and percutaneous coronary interventions with drug-eluting stents: Does the K/DOQI classification matter? 81
Coronary Flow Velocity Reserve by Contrast-Enhanced Transthoracic Echocardiography Predicts Maximal Epicardial Intimal Thickening in Cardiac Allograft Vasculopathy 79
Moderate-to-severe ischemic mitral regurgitation and multivessel coronary artery disease: Impact of different treatment on survival and rehospitalization. 79
Ventricular assist devices. 78
"Of coronary arteries and men": The fight of a dialysis patient against his coronary arteries 78
Transcatheter aortic valve implantation and bleeding: focus on Valve Academic Research Consortium-2 classification. 76
Impact of multivessel coronary artery disease on early ischemic injury, late clinical outcome, and remodeling in patients with acute myocardial infarction treated by primary coronary angioplasty. 76
A combination of drug-eluting stents and bioresorbable vascular scaffolds in the treatment of multivessel coronary artery disease 76
Impact of coronary artery disease in elderly patients undergoing transcatheter aortic valve implantation: Insight from the Italian CoreValve Registry. 76
Comment to 'Video-assisted minimally invasive mitral valve surgery: transitioning from sternotomy to mini-thoracotomy'. 75
Inaccuracy of available surgical risk scores to predict outcomes after transcatheter aortic valve replacement. 74
Time-dependent detrimental effects of distal embolization on myocardium and microvasculature during primary percutaneous coronary intervention. 74
Transcatheter aortic valve implantation in low ejection fraction/low transvalvular gradient patients: the rule of 40 74
Direct intramyocardial percutaneous delivery of autologous bone marrow in patients with refractory myocardial angina 74
Unmasking Myocardial Bridge-Related Ischemia by Intracoronary Functional Evaluation 74
Conduction disorders in the setting of transcatheter aortic valve implantation: a clinical perspective 73
Acceptable reperfusion delay to prefer primary angioplasty over fibrin-specific thrombolytic therapy is affected (mainly) by the patient's mortality risk: 1 h does not fit all. 73
Incidence and predictors of early and late mortality after transcatheter aortic valve implantation in 663 patients with severe aortic stenosis 73
Transcatheter aortic valve implantation and bleeding: Focus on Valve Academic Research Consortium-2 classification. 73
Patient risk profile and benefit from an invasive approach in the initial management of non-ST-segment elevation acute coronary syndrome 73
Prevalence and Impact of Atrial Fibrillation in Patients with Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement An Analysis from the SOURCE XT Prospective Multicenter Registry 72
Positive stress test in a patient with patent coronary artery grafts 72
Transcatheter aortic valve implantation in patients younger than 75 years: Guidelines-based patients selection and clinical outcome 72
Valutazione della perfusione miocardica dopo angioplastica primaria: correlazione tra myocardial blush grade, staining angiografico e danno micro vascolare alla risonanza magnetica cardiaca 71
LAD coronary artery myocardial bridging and apical ballooning syndrome. 71
Transcatheter valve-in-valve implantation using CoreValve revalving system for failed surgical aortic bioprostheses 71
Potential role of circulating progenitor cells in coronary microvascular dysfunction of heart transplant patients with normal coronary angiograms 70
Relationship between pattern of slow-reflow and tissue level of perfusion after coronary stenting: A single-patient report 70
Age-related outcome of percutaneous mitral balloon valvuloplasty 69
The Contribution of Intramyocardial Hemorrhage to the No-reflow Phenomenon: A Study Performed by Cardiac Magnetic Resonance 69
Impact of drug-eluting stent generation on patient- and stent-related adverse events of diabetic patients treated by percutaneous coronary intervention. 69
Intermediate clinical and hemodynamic outcomes after transcatheter aortic valve implantation presented at the fifty-first annual meeting of the society of thoracic surgeons, San Diego, CA, Jan 24-28, 2015 69
Mid-term prognostic value of coronary artery disease in patients undergoing transcatheter aortic valve implantation: A meta-analysis of adjusted observational results 68
Coronary flow reserve by contrast-enhanced transthoracic Echocardiography predicts maximal epicardial intimal thickness in heart transplant patients with normal coronary angiogram 67
Transfemoral aortic valve implantation of an Edwards Sapien XT valve in a patient with a mechanical mitral prosthesis. 67
Thrombus burden and myocardial damage during primary percutaneous coronary intervention. 67
Impact of age on immediate and late results of percutaneous mitral balloon valvuloplasty in a series of 626 patients. 66
The interplay between permanent pacemaker implantation and mortality in patients treated by transcatheter aortic valve implantation: A systematic review and meta-analysis 66
Comparison of Variables in Men Versus Women Undergoing Transcatheter Aortic Valve Implantation for Severe Aortic Stenosis (from Italian Multicenter CoreValve Registry) 66
Conduction Abnormalities after Transcatheter Aortic Valve Implantation for Calcitic Aortic Valve Disease 65
Adjusting the benefits of primary angioplasty against thrombolytic therapy for acute myocardial infarction: the role of time 65
Survival benefits of primary angioplasty over thrombolysis after adjustment for percutaneous transluminal coronary angioplasty related time delay 65
Three-dimensional electroanatomic voltage mapping increases accuracy of diagnosing arrhythmogenic right ventricular cardiomyopathy/dysplasia 64
Neo-atherosclerosis in very late stent thrombosis of drug eluting stent 64
Coronary flow reserve by contrast-enhanced transthoracic echocardiography predicts cardiac allograft vasculopathy onset in heart transplant patients with normal coronary angiogram 63
Transcatheter aortic valve implantation in failed bioprosthetic surgical valves 63
Six-year clinical outcomes of first-generation drug-eluting stents: a propensity-matched analysis. 63
Percutaneous treatment of spontaneous coronary artery dissection 62
Patient risk profile and benefit from an invasive approach in the initial management of non-ST-segment elevation acute coronary syndrome 62
Initial Q Wave at Presentation of Acute Myocardial Infarction is Better Than Time to Treatment in Predicting Myocardial and Microvascular Damage in Patients with Anterior Acute Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention 62
Totale 8.298
Categoria #
all - tutte 40.676
article - articoli 39.690
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 178
Totale 80.544


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019813 0 0 0 0 0 0 0 0 0 0 441 372
2019/20202.523 399 79 45 157 261 227 229 328 250 234 211 103
2020/20211.569 72 106 29 126 85 144 75 128 270 137 225 172
2021/20222.421 47 367 259 169 85 192 124 242 101 36 238 561
2022/20232.114 429 262 87 257 316 257 6 132 233 20 86 29
2023/2024600 26 146 83 56 74 62 42 54 44 13 0 0
Totale 12.026